Stage Cell Therapeutics

Gottingen, Germany Founded: 2005 • Age: 21 yrs Acquired By Juno Therapeutics
Technology for cell therapeutics development and production is provided.
Request Access

About Stage Cell Therapeutics

Stage Cell Therapeutics is a company based in Gottingen (Germany) founded in 2005 was acquired by Juno Therapeutics in May 2015.. The company has 77 employees as of December 31, 2021. Stage Cell Therapeutics operates in a competitive market with competitors including Abcam, Stem Cell Technologies, BioLife Solutions, RoosterBio and Shanghai Doning Biotechnology, among others.

  • Headquarter Gottingen, Germany
  • Employees 77 as on 31 Dec, 2021
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Juno Therapeutics Gmbh
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Biotechnology, Genomics & Life Sciences Research
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    77

    as on Dec 31, 2021

  • Acquired by
    Juno Therapeutics

    (May 11, 2015)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Stage Cell Therapeutics

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Stage Cell Therapeutics

Stage Cell Therapeutics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Juno Therapeutics. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
CAR T-cell and T-cell receptor immunotherapies for cancer are developed.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Stage Cell Therapeutics

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Stage Cell Therapeutics

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Stage Cell Therapeutics Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Stage Cell Therapeutics

Stage Cell Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Abcam, Stem Cell Technologies, BioLife Solutions, RoosterBio and Shanghai Doning Biotechnology, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Biological reagents and antibodies are developed for life science research.
domain founded_year HQ Location
Developer of cell culture media and ancillary reagents for life science research
domain founded_year HQ Location
Tissue hypothermic storage and cryopreservation freeze media are developed.
domain founded_year HQ Location
Developer of human mesenchymal stem cells and extracellular vesicles
domain founded_year HQ Location
Serum-free cell culture media is supplied to biopharmaceutical industries.
domain founded_year HQ Location
Transfection Solutions for Healthcare and Life Sciences organizations
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Stage Cell Therapeutics

Frequently Asked Questions about Stage Cell Therapeutics

When was Stage Cell Therapeutics founded?

Stage Cell Therapeutics was founded in 2005.

Where is Stage Cell Therapeutics located?

Stage Cell Therapeutics is headquartered in Gottingen, Germany. It is registered at Gottingen, Niedersachsen, Germany.

How many employees does Stage Cell Therapeutics have?

As of Dec 31, 2021, the latest employee count at Stage Cell Therapeutics is 77.

What does Stage Cell Therapeutics do?

Stage Cell Therapeutics was founded in 2005 in Gottingen, Germany, within the biotechnology sector focused on cell therapeutics. A proprietary Streptamer technology was developed to facilitate the isolation and expansion of lymphocytes using clinical isolation kits. Reagents for manufacturing novel cell therapeutics are also produced through this platform. The company was acquired by Juno Therapeutics in May 2015.

Who are the top competitors of Stage Cell Therapeutics?

Stage Cell Therapeutics's top competitors include Abcam, RoosterBio and BioLife Solutions.

Who are Stage Cell Therapeutics's investors?

Stage Cell Therapeutics has 1 investor. Key investors include Juno Therapeutics.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available